Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes (2006)
- Authors:
- USP affiliated authors: WAJCHENBERG, BERNARDO LEO - FM ; FUKUI, ROSA TSUNECHIRO - FM ; ROCHA, DALVA MARREIRO - FM
- Unidade: FM
- Subjects: FIBRINÓLISE; MENOPAUSA; DIABETES MELLITUS; TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS; RESUMOS (CONGRESSOS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Resumos
- Conference titles: ENDO 06 - Annual Meeting the endocrine society's
-
ABNT
SZTEJNSZNAJD, Claudia; SILVA, Maria Elizabeth R.; MACHADO, Helena A.; et al. Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes. Anais.. Boston: [s.n.], 2006. -
APA
Sztejnsznajd, C., Silva, M. E. R., Machado, H. A., Amico, E. A. D., Rocha, T. R. F., Rocha, D. M., et al. (2006). Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes. In Resumos. Boston. -
NLM
Sztejnsznajd C, Silva MER, Machado HA, Amico EAD, Rocha TRF, Rocha DM, Fukui RT, Correia MRS, Santos RF, Wajchenberg BL. Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes. Resumos. 2006 ; -
Vancouver
Sztejnsznajd C, Silva MER, Machado HA, Amico EAD, Rocha TRF, Rocha DM, Fukui RT, Correia MRS, Santos RF, Wajchenberg BL. Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes. Resumos. 2006 ; - Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients
- Differential regulation of PGC-1α expression in rat liver and skeletal muscle in response to voluntary running
- Estrogênios conjugados equinos melhoram a complacência vascular em mulheres diabéticas menopausadas
- Efeitos metabólicos e na reatividade vascular de glimepiride e metformina em pacientes com diabetes tipo 2.
- Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients
- Non-Islet Autoantibodies (Non-IsletAAb): Prevalence and Association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients
- Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study
- Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
